Zavesca
Zavesca is a medicine authorised by Swissmedic under authorisation number 56898. The authorisation holder is Janssen-Cilag AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 22 October 2004 and the authorisation is valid without a time limit. ATC code A16AX06 places the medicine in the group Other alimentary tract and metabolism products.
| Authorisation number | 56898 |
|---|---|
| Name | Zavesca |
| Full name | Zavesca, Kapseln |
| Authorisation holder | Janssen-Cilag AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A16AX06 |
| First authorisation | 22 October 2004 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Zavesca, Kapseln | B | 22 October 2004 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 84 | Kapsel(n) | A16AX06 | 07.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Zavesca authorised in Switzerland?
Yes. Zavesca is authorised by Swissmedic under authorisation number 56898, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Zavesca have?
Zavesca is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Zavesca?
The authorisation holder is Janssen-Cilag AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.